Protease inhibitors and adipocyte differentiation in cell culture

Lancet

Volumn 352, Issue 9133, 1998, Pages 1032-

  Gagnon, AnneMarie ^b   Angel, Jonathan B ^b   Sorisky, Alexander ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032569459     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60074-8     Document Type: Article

References (5)

1. 1 Carr A, Samara K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1998; 351: 1881-83.
2. 2 Hirsch J, Fried SK, Edens NK, Leibel RL. The fat cell. Med Clin North Am 1989; 73: 83-96.
3. 3 Cornelius P, MacDougald OA, Lane MD. Regulation of adipocyte development. Ann Rev Nutr 1994; 14: 99-129.
4. 4 Gagnon AM, Sorisky A. Extracellular matrix induced by TGFβ impairs insulin signal transduction in 3T3-L1 preadipose cells. J Cell Physiol 1998; 175: 370-78.
5. 5 He GP, Muise A, Li AW, Ro HS. A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature 1995; 378: 92-96.